Related Experiment Video

Updated: Sep 13, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy

Krishnendu Adhikary1, Abhik Paul2, Ayush Madan3

  • 1Department of Interdisciplinary Science, Centurion University of Technology and Management, Odisha, India.

Advances in Immunology
|July 30, 2025
PubMed

Insights

Messenger RNA (mRNA) cancer vaccines, like mRNA-4157/V940, are emerging as advanced immunotherapies. These personalized vaccines, combined with pembrolizumab, show promise in boosting T cell responses against melanoma.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Melanoma incidence is rising, necessitating novel therapeutic strategies.
  • Traditional cancer vaccines target tumor-associated antigens, with limited efficacy.
  • Advancements in messenger RNA (mRNA) technology, spurred by the COVID-19 pandemic, offer new possibilities for cancer vaccines.

Purpose of the Study:

  • To review the preclinical and clinical progress of mRNA-based cancer vaccines for melanoma.
  • To highlight manufacturing challenges and solutions in the development of mRNA melanoma vaccines.

Main Methods:

  • Development of mRNA-4157/V940, a personalized cancer vaccine encoding 34 patient-specific tumor neoantigens.
  • Combination therapy involving mRNA-4157/V940 and pembrolizumab (a PD-1 inhibitor).
  • Assessment of T cell responses tailored to individual tumor mutational patterns.

Main Results:

  • Early clinical trials indicate that the combination of mRNA-4157/V940 and pembrolizumab enhances T cell-mediated tumor killing.
  • The vaccine instructs the immune system to differentiate between healthy and malignant cells.
  • Pembrolizumab's mechanism involves suppressing PD-1, PD-L1, and PD-L2 pathways.

Conclusions:

  • Personalized mRNA cancer vaccines represent a promising frontier in advanced immunotherapy.
  • The combination of mRNA vaccines and checkpoint inhibitors like pembrolizumab may significantly improve melanoma treatment outcomes.
  • Continued research and clinical trials are crucial for addressing manufacturing and efficacy challenges.
Keywords:
COVID-19Drug deliveryImmunotherapeutic methodMRNA vaccinesMelanomaNanoparticles

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

800

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K